Consequently, strategies aimed at stabilizing EPLIN during early cancer stages or reinstating its function during metastasis could serve as pivotal therapeutic avenues for cancer treatments involving protease inhibitors alongside investigations centered on p53-related mechanisms. Here, TP53 is linked to cancer.